Featured Research

from universities, journals, and other organizations

New understanding of biomarkers could lead to earlier diagnosis of fatal diseases

Date:
July 17, 2011
Source:
National Physical Laboratory
Summary:
A new research paper sheds light on the way antibodies distinguish between different but closely related "biomarkers" -- proteins which reveal information about the condition of the human body. This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases.

A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' -- proteins which reveal information about the condition of the human body. This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases.

Related Articles


All diseases have proteins, or concentrations of proteins, specifically linked to them called biomarkers. Identifying these can prove a powerful diagnostic tool. These biomarkers are detected by immunoassays -- a test which mixes a substance (eg blood, urine) with antibodies, which bind to the protein if it is present. The antibodies can then be measured to identify the level of the biomarker, which in turn indicates the presence and extent of an illness.

Antibodies bind with high specificity to one protein molecule or a limited group of molecules (eg hormones), which is why we can use antibodies to test for specific biomarkers. Problems arise when they bind to groups of similar hormones that are associated with normal bodily changes. This leads to false positives and therefore unreliable information.

New research, carried out by the National Physical Laboratory (NPL), the University of Edinburgh and industrial partners from the UK (Mologic ltd), US (IBM's Watson Research Center) and the Netherlands (Pepscan Presto BV), changes this. The research shows how different proteins are made up, and therefore how they can be identified reliably.

The highly sought solution is 'intelligent selection' of antibody-specific interaction sites on hormones that can differ from similar sites of other hormones by just one molecule.

The research focused on hCG (human chorionic gonadotropin), a hormone produced during pregnancy. A subunit of hCG -- hCGβ -- is secreted by some cancers, meaning detection can give early warning of tumors.

hCG is very similar to other reproductive hormones, known as LH and FSH, which are always present in the body. Detecting hCG can be confused with these other hormones, leading to unreliable results.

The immunoassay antibodies bind to a tiny part of the hormone called an epitope. Hormones are made up of thousands of 'building blocks', with epitopes making up less than 10 of these blocks. The difference between hormones can be as little as one of these epitope blocks.

The research team took a variety of precise measurements of the hCG hormone.

The team showed how very subtle, atomic level characteristics define the antibody selectivity in closely related epitopes of different proteins. They identified that specific antibodies are highly selective in immunoassays and can distinguish between hCGβ and closely related LH fragments.

Understanding these structural differences explains the observed selectivity in the full hormones. Armed with this knowledge, scientists can develop intelligent epitope selection to achieve the required assay performance. This means reliable tests can be developed to identify the presence of different hormones -- in this case the presence of hCGβ which indicates cancer, as opposed to LH, which is always present.

The advances described in this research will enable development of further immunoassays to identify other biomarkers from similar groups. Pharmaceutical companies could use this to develop new technologies for diagnostics and clinical disease treatments, for example tests for tumour as part of routine screenings.

Max Ryadnov, Principal Research Scientist at the National Physical Laboratory, says "This work answers one of the big questions in distinguishing biomarkers which are critical for identifying and treating serious diseases. We hope this breakthrough will underpin the development of a range of new diagnostic techniques and treatment."

Prof Paul Davis, Chief Scientific Officer of Mologic ltd -- a UK diagnostic company that initiated the study, said: "It was a great collaborative effort, and it stands as a fine example of what can be achieved when motivated scientists work together openly across boundaries."

This research is a part of the NPL-led international research project 'Multiscale measurements in biophysical systems', which is jointly funded by NPL and the Scottish Universities Physics Alliance.


Story Source:

The above story is based on materials provided by National Physical Laboratory. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. R. Gregor, E. Cerasoli, J. Schouten, J. Ravi, J. Slootstra, A. Horgan, G. J. Martyna, M. G. Ryadnov, P. Davis, J. Crain. Antibody Recognition of a Human Chorionic Gonadotropin Epitope (hCG 66-80) Depends on Local Structure Retained in the Free Peptide. Journal of Biological Chemistry, 2011; 286 (28): 25016 DOI: 10.1074/jbc.M111.246637

Cite This Page:

National Physical Laboratory. "New understanding of biomarkers could lead to earlier diagnosis of fatal diseases." ScienceDaily. ScienceDaily, 17 July 2011. <www.sciencedaily.com/releases/2011/07/110715135132.htm>.
National Physical Laboratory. (2011, July 17). New understanding of biomarkers could lead to earlier diagnosis of fatal diseases. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/07/110715135132.htm
National Physical Laboratory. "New understanding of biomarkers could lead to earlier diagnosis of fatal diseases." ScienceDaily. www.sciencedaily.com/releases/2011/07/110715135132.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins